( September 24, 2025, 1:05 PM EDT) -- SEATTLE — A Washington federal judge refused to sign off on a joint motion filed by Eli Lilly and Co., two medical centers and two of their physicians who prescribe patients compounded versions of tirzepatide XE "tirzepatide" , a Food and Drug Administration-approved drug for diabetes and weight loss, for a consent judgment and permanent injunction to end a trademark case, finding that the motion “suffers from numerous defects.”...